FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Panel to Discuss Novartis NDA for Cushings Disease

[ Price : $8.95]

Federal Register Notice: FDAs Endocrinologic and Metabolic Drugs Advisory Committee will meet 11/7 to discuss a Novartis NDA for S...

Panel to be Updated on CDER, CBER Research Programs

[ Price : $8.95]

Federal Register Notice: FDA plans a teleconference meeting of the Cellular, Tissue and Gene Therapies Advisory Committee 11/29 to...

OCI Agents Looking at Compounding Center

[ Price : $8.95]

The Boston Globe says FDA Office of Criminal Investigations agents are participating in the agencys probe of the New England Compo...

Vivus Submits Amended REMS for Obesity Drug

[ Price : $8.95]

Vivus submits an amendment to its REMS for obesity drug Qsymia to allow dispensing through a broader range of certified pharmacies...

FDA Panel Backs Hypercholesterolemia Drug

[ Price : $8.95]

FDAs Endocrinologic and Metabolic Drugs Advisory Committee votes to recommend approval for Aegerion Pharmaceuticals lomitapide mes...

FDA Approves Exjade Boxed Warning, Other Changes

[ Price : $8.95]

FDA approves a Boxed Warning in labeling for Novartis Exjade and labeling changes for 59 other drugs.

NIH Opens Drug Liver Injury Database

[ Price : $8.95]

NIH opens its LiverTox database to give healthcare professionals and researchers information on Rx and OTC drug-induced liver inju...

FTC Reiterating Views on Anticompetitive No AG Agreements

[ Price : $8.95]

FTC asks a New Jersey federal court for permission to file a brief stating its position that GlaxoSmithKline made an anti-competit...

High Court Brushes Off Warning Letter Case

[ Price : $8.95]

The U.S. Supreme Court passes on a Warning Letter case and whether such communications are final agency actions and reviewable in ...

Advisors Back NPS Gattex for Short Bowel Syndrome

[ Price : $8.95]

Members of FDAs Gastrointestinal Drugs Advisory Committee recommend the agency approve NPS Gattex for adults with short bowel synd...